PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the company will make presentations at the following upcoming events.
25th Conference of the Asian Pacific Association for the Study of the Liver – Tokyo, February 20-24, 2016
February 22, 1:30 p.m. JST – Man-Fung Yuen, M.D., Ph.D., chair of gastroenterology and hepatology, The University of Hong Kong, and deputy chief of service, Queen Mary Hospital department of medicine, Hong Kong, and coauthors, will deliver an oral presentation titled, “Effective Inhibition of cccDNA Derived mRNA/Viral Antigens and Tolerability with ARC-520”
25th Conference of the Asian Pacific Association for the Study of the Liver – Tokyo, February 20-24, 2016
February 22, 1:30 p.m. JST – Man-Fung Yuen, M.D., Ph.D., chair of gastroenterology and hepatology, The University of Hong Kong, and deputy chief of service, Queen Mary Hospital department of medicine, Hong Kong, and coauthors, will deliver an oral presentation titled, “Effective Inhibition of cccDNA Derived mRNA/Viral Antigens and Tolerability with ARC-520”
